Latest filing published 25 Jun 2026 for Rhythm Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Stuart A. Arbuckle span 5 companies, the busiest being Vertex Pharmaceuticals INC / MA, ImmunoGen, Inc. and Praxis Precision Medicines, Inc. We count 52 filings; the first trade dates from 2 February 2016 and the latest from 23 June 2026.
On the market, this insider has only sold: 13 sales, €1.8M in total. The totals do not cover 4 filings with an undisclosed amount. Other entries cover 30 share grants and 8 option exercises.
Most recently, on 25 June 2026, the filings show an option exercise in Rhythm Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 52 declarations